1. kickoff-deck-generateSUCCEEDED
{
"output": {
"deckOutline": {
"Title": "Kickoff Deck Outline: US Payer Coverage and Market Access Research for Obesity Therapies",
"1. Deck objective": {
"Deck objective": "Align the team on the research scope, key questions, source strategy, and deliverables for a US payer market access assessment of anti-obesity therapies, so the work can inform payer engagement, value proposition development, and evidence planning ahead of launch."
},
"6. Immediate next steps": [
"Client to confirm priority payer segments and target therapies.",
"Client to share any existing access assumptions and source materials.",
"Research team to finalize source plan and segmentation framework.",
"Research team to build a policy tracking template.",
"Schedule kickoff readout and confirm interim review date."
],
"5. Risks and open questions": [
"Payer policy can change quickly, so findings may age fast.",
"Published policies may not reflect actual adjudication behavior.",
"Medicare Advantage and commercial payer views may differ materially.",
"Evidence expectations may be inconsistent across payer segments.",
"Outcomes-based contracting examples may be limited or not fully public.",
"Scope may expand if specific products or payer segments are not clarified early."
],
"4. Materials and inputs to request": [
"Any existing payer landscape or access assumptions",
"Target product list or priority comparators",
"Known payer list or segments to include",
"Prior research, field notes, or interview learnings",
"Internal evidence strategy or value story drafts",
"Competitor access intelligence or policy trackers",
"Any client-approved source list or constraints",
"Timing, launch milestones, and decision deadlines"
],
"3. Recommended kickoff deck outline": {
"Slide 1": {
"Purpose": "Set the purpose of the research and confirm how it will be used.",
"Slide title": "Why we are here",
"Key topics to cover": [
"Research objective",
"Business decision(s) the work should inform",
"Intended audience for outputs"
],
"Critical decisions, questions, or confirmations": [
"Confirm the main use case: payer engagement, value story, or evidence plan.",
"Confirm expected decision support at project close."
]
},
"Slide 2": {
"Purpose": "Define the precise boundaries of the assessment.",
"Slide title": "Scope and research questions",
"Key topics to cover": [
"Target therapies/class of interest",
"US payer segments in scope",
"Core research questions on coverage, UM, evidence, and value drivers"
],
"Critical decisions, questions, or confirmations": [
"Confirm which payer types are highest priority.",
"Confirm whether the scope includes only obesity or also diabetes-adjacent comparators."
]
},
"Slide 3": {
"Purpose": "Summarize the baseline understanding that frames the research.",
"Slide title": "What we already know about the market context",
"Key topics to cover": [
"Current coverage environment",
"Common access barriers for obesity therapies",
"Recent shifts in payer behavior"
],
"Critical decisions, questions, or confirmations": [
"Validate whether the team has a current hypothesis on payer resistance or adoption patterns."
]
},
"Slide 4": {
"Purpose": "Translate the topic into testable market access hypotheses.",
"Slide title": "Hypotheses to test",
"Key topics to cover": [
"Most important value drivers",
"Expected evidence gaps",
"Likely utilization management levers"
],
"Critical decisions, questions, or confirmations": [
"Confirm the hypotheses the client wants pressure-tested.",
"Agree on whether cardiovascular benefit or long-term outcomes are core proof points."
]
},
"Slide 5": {
"Purpose": "Align on how payer views will be organized and compared.",
"Slide title": "Payer segmentation approach",
"Key topics to cover": [
"National vs regional commercial payers",
"PBMs",
"Medicare Advantage organizations",
"Possible segmentation by access posture"
],
"Critical decisions, questions, or confirmations": [
"Confirm segmentation criteria and any named payers to prioritize.",
"Confirm whether to include employer-sponsored plan dynamics separately."
]
},
"Slide 6": {
"Purpose": "Show how insights will be built from published and gray sources.",
"Slide title": "Evidence and source strategy",
"Key topics to cover": [
"Policy documents",
"Conference presentations",
"Advisory board learnings",
"Reimbursement trend analyses"
],
"Critical decisions, questions, or confirmations": [
"Confirm acceptable source hierarchy and any must-use sources.",
"Confirm whether payer interview/advisory input is part of the plan."
]
},
"Slide 7": {
"Purpose": "Clarify the specific payer policy elements that will be assessed.",
"Slide title": "Coverage and utilization management lens",
"Key topics to cover": [
"Prior authorization",
"Step therapy",
"Formulary tiering/positioning",
"Reauthorization and continuation criteria"
],
"Critical decisions, questions, or confirmations": [
"Confirm the policy elements that matter most to the client.",
"Confirm whether the team should benchmark by payer type or by policy strictness."
]
},
"Slide 8": {
"Purpose": "Align on which outcomes will matter most to payers.",
"Slide title": "Evidence expectations and value drivers",
"Key topics to cover": [
"Long-term outcomes",
"Cardiovascular benefit",
"Adherence/persistence",
"Healthcare cost offsets",
"Real-world evidence needs"
],
"Critical decisions, questions, or confirmations": [
"Confirm the evidence endpoints to prioritize.",
"Clarify whether economic value or clinical value should lead the narrative."
]
},
"Slide 9": {
"Purpose": "Frame the competitive and contracting context.",
"Slide title": "Competitor and contracting landscape",
"Key topics to cover": [
"Competitor payer positioning strategies",
"Any observed access advantages/disadvantages",
"Emerging outcomes-based contracting models"
],
"Critical decisions, questions, or confirmations": [
"Confirm whether competitor benchmarking is required at brand or class level.",
"Confirm the desired level of detail on contracting models."
]
},
"Slide 10": {
"Purpose": "Close alignment on outputs, milestones, and review gates.",
"Slide title": "Deliverables, timing, and decision points",
"Key topics to cover": [
"Expected deliverables",
"Key interim readouts",
"Final synthesis format",
"Timing dependencies"
],
"Critical decisions, questions, or confirmations": [
"Confirm review checkpoints and final delivery date.",
"Confirm who signs off on direction changes."
]
},
"Slide 11": {
"Purpose": "Make ownership and next actions explicit.",
"Slide title": "Immediate next steps",
"Key topics to cover": [
"Client inputs needed",
"Research team actions",
"Timeline for first draft and interim check-in"
],
"Critical decisions, questions, or confirmations": [
"Confirm owners for source sharing and stakeholder access.",
"Confirm date for first progress update."
]
}
},
"2. What we know / assumptions / gaps": {
"Assumptions": [
"The project will support a launch-stage market access strategy, not a retrospective academic review.",
"The client wants actionable payer insights, not just a literature summary.",
"Competitor positioning and contracting trends are relevant to the final output."
],
"Known facts": [
"Geography is the United States.",
"Focus is on commercial payers, PBMs, and Medicare Advantage organizations.",
"Target topic is coverage, reimbursement, utilization management, and value assessment for anti-obesity pharmacotherapies, including GLP-1 and dual agonist therapies.",
"Priority topics include prior authorization, step therapy, formulary positioning, evidence expectations, and outcomes-based contracting.",
"Timeframe emphasis is the last 12 to 18 months.",
"Both published and gray literature sources are in scope."
],
"Gaps to confirm": [
"Which products or companies are the primary focus, if any.",
"Which payer segments matter most by priority.",
"Expected deliverable format, depth, and timeline.",
"Whether the output should include a current-state map, payer segmentation, or recommendation framework.",
"Any excluded evidence types, payer types, or geographies within the US."
]
}
}
},
"status": "completed",
"rawProviderText": "{\"deckOutline\":{\"Title\":\"Kickoff Deck Outline: US Payer Coverage and Market Access Research for Obesity Therapies\",\"1. Deck objective\":{\"Deck objective\":\"Align the team on the research scope, key questions, source strategy, and deliverables for a US payer market access assessment of anti-obesity therapies, so the work can inform payer engagement, value proposition development, and evidence planning ahead of launch.\"},\"2. What we know / assumptions / gaps\":{\"Known facts\":[\"Geography is the United States.\",\"Focus is on commercial payers, PBMs, and Medicare Advantage organizations.\",\"Target topic is coverage, reimbursement, utilization management, and value assessment for anti-obesity pharmacotherapies, including GLP-1 and dual agonist therapies.\",\"Priority topics include prior authorization, step therapy, formulary positioning, evidence expectations, and outcomes-based contracting.\",\"Timeframe emphasis is the last 12 to 18 months.\",\"Both published and gray literature sources are in scope.\"],\"Assumptions\":[\"The project will support a launch-stage market access strategy, not a retrospective academic review.\",\"The client wants actionable payer insights, not just a literature summary.\",\"Competitor positioning and contracting trends are relevant to the final output.\"],\"Gaps to confirm\":[\"Which products or companies are the primary focus, if any.\",\"Which payer segments matter most by priority.\",\"Expected deliverable format, depth, and timeline.\",\"Whether the output should include a current-state map, payer segmentation, or recommendation framework.\",\"Any excluded evidence types, payer types, or geographies within the US.\"]},\"3. Recommended kickoff deck outline\":{\"Slide 1\":{\"Slide title\":\"Why we are here\",\"Purpose\":\"Set the purpose of the research and confirm how it will be used.\",\"Key topics to cover\":[\"Research objective\",\"Business decision(s) the work should inform\",\"Intended audience for outputs\"],\"Critical decisions, questions, or confirmations\":[\"Confirm the main use case: payer engagement, value story, or evidence plan.\",\"Confirm expected decision support at project close.\"]},\"Slide 2\":{\"Slide title\":\"Scope and research questions\",\"Purpose\":\"Define the precise boundaries of the assessment.\",\"Key topics to cover\":[\"Target therapies/class of interest\",\"US payer segments in scope\",\"Core research questions on coverage, UM, evidence, and value drivers\"],\"Critical decisions, questions, or confirmations\":[\"Confirm which payer types are highest priority.\",\"Confirm whether the scope includes only obesity or also diabetes-adjacent comparators.\"]},\"Slide 3\":{\"Slide title\":\"What we already know about the market context\",\"Purpose\":\"Summarize the baseline understanding that frames the research.\",\"Key topics to cover\":[\"Current coverage environment\",\"Common access barriers for obesity therapies\",\"Recent shifts in payer behavior\"],\"Critical decisions, questions, or confirmations\":[\"Validate whether the team has a current hypothesis on payer resistance or adoption patterns.\"]},\"Slide 4\":{\"Slide title\":\"Hypotheses to test\",\"Purpose\":\"Translate the topic into testable market access hypotheses.\",\"Key topics to cover\":[\"Most important value drivers\",\"Expected evidence gaps\",\"Likely utilization management levers\"],\"Critical decisions, questions, or confirmations\":[\"Confirm the hypotheses the client wants pressure-tested.\",\"Agree on whether cardiovascular benefit or long-term outcomes are core proof points.\"]},\"Slide 5\":{\"Slide title\":\"Payer segmentation approach\",\"Purpose\":\"Align on how payer views will be organized and compared.\",\"Key topics to cover\":[\"National vs regional commercial payers\",\"PBMs\",\"Medicare Advantage organizations\",\"Possible segmentation by access posture\"],\"Critical decisions, questions, or confirmations\":[\"Confirm segmentation criteria and any named payers to prioritize.\",\"Confirm whether to include employer-sponsored plan dynamics separately.\"]},\"Slide 6\":{\"Slide title\":\"Evidence and source strategy\",\"Purpose\":\"Show how insights will be built from published and gray sources.\",\"Key topics to cover\":[\"Policy documents\",\"Conference presentations\",\"Advisory board learnings\",\"Reimbursement trend analyses\"],\"Critical decisions, questions, or confirmations\":[\"Confirm acceptable source hierarchy and any must-use sources.\",\"Confirm whether payer interview/advisory input is part of the plan.\"]},\"Slide 7\":{\"Slide title\":\"Coverage and utilization management lens\",\"Purpose\":\"Clarify the specific payer policy elements that will be assessed.\",\"Key topics to cover\":[\"Prior authorization\",\"Step therapy\",\"Formulary tiering/positioning\",\"Reauthorization and continuation criteria\"],\"Critical decisions, questions, or confirmations\":[\"Confirm the policy elements that matter most to the client.\",\"Confirm whether the team should benchmark by payer type or by policy strictness.\"]},\"Slide 8\":{\"Slide title\":\"Evidence expectations and value drivers\",\"Purpose\":\"Align on which outcomes will matter most to payers.\",\"Key topics to cover\":[\"Long-term outcomes\",\"Cardiovascular benefit\",\"Adherence/persistence\",\"Healthcare cost offsets\",\"Real-world evidence needs\"],\"Critical decisions, questions, or confirmations\":[\"Confirm the evidence endpoints to prioritize.\",\"Clarify whether economic value or clinical value should lead the narrative.\"]},\"Slide 9\":{\"Slide title\":\"Competitor and contracting landscape\",\"Purpose\":\"Frame the competitive and contracting context.\",\"Key topics to cover\":[\"Competitor payer positioning strategies\",\"Any observed access advantages/disadvantages\",\"Emerging outcomes-based contracting models\"],\"Critical decisions, questions, or confirmations\":[\"Confirm whether competitor benchmarking is required at brand or class level.\",\"Confirm the desired level of detail on contracting models.\"]},\"Slide 10\":{\"Slide title\":\"Deliverables, timing, and decision points\",\"Purpose\":\"Close alignment on outputs, milestones, and review gates.\",\"Key topics to cover\":[\"Expected deliverables\",\"Key interim readouts\",\"Final synthesis format\",\"Timing dependencies\"],\"Critical decisions, questions, or confirmations\":[\"Confirm review checkpoints and final delivery date.\",\"Confirm who signs off on direction changes.\"]},\"Slide 11\":{\"Slide title\":\"Immediate next steps\",\"Purpose\":\"Make ownership and next actions explicit.\",\"Key topics to cover\":[\"Client inputs needed\",\"Research team actions\",\"Timeline for first draft and interim check-in\"],\"Critical decisions, questions, or confirmations\":[\"Confirm owners for source sharing and stakeholder access.\",\"Confirm date for first progress update.\"]}},\"4. Materials and inputs to request\":[\"Any existing payer landscape or access assumptions\",\"Target product list or priority comparators\",\"Known payer list or segments to include\",\"Prior research, field notes, or interview learnings\",\"Internal evidence strategy or value story drafts\",\"Competitor access intelligence or policy trackers\",\"Any client-approved source list or constraints\",\"Timing, launch milestones, and decision deadlines\"],\"5. Risks and open questions\":[\"Payer policy can change quickly, so findings may age fast.\",\"Published policies may not reflect actual adjudication behavior.\",\"Medicare Advantage and commercial payer views may differ materially.\",\"Evidence expectations may be inconsistent across payer segments.\",\"Outcomes-based contracting examples may be limited or not fully public.\",\"Scope may expand if specific products or payer segments are not clarified early.\"],\"6. Immediate next steps\":[\"Client to confirm priority payer segments and target therapies.\",\"Client to share any existing access assumptions and source materials.\",\"Research team to finalize source plan and segmentation framework.\",\"Research team to build a policy tracking template.\",\"Schedule kickoff readout and confirm interim review date.\"]}}",
"providerResponseId": "resp_016eda64490bcbcb006a04d39154dc8196b5e0c6ae58455fd3"
}